Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2016

Open Access 01-12-2016 | Research

Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators

Authors: Peter Magnusson, Stellan Mörner, Fredrik Gadler, Jan Karlsson

Published in: Health and Quality of Life Outcomes | Issue 1/2016

Login to get access

Abstract

Background

Health-related quality of life (HRQL) in hypertrophic cardiomyopathy (HCM) patients with implantable cardioverter-defibrillators (ICDs) is largely unknown. The aim was to assess HRQL, including comparisons between groups, using the questionnaire SF-36, and compare it to a Swedish age- and sex-matched population.

Methods and Results

Validated data on adult HCM patients with ICDs were used. The SF-36 response rate was 82.5 % and 245 patients (mean age 55.9 years, 70.2 % men) were analyzed using the Mann-Whitney U-test, t-test, Spearman correlation and effect size calculations. In all SF-36 domains the patients’ score was lower (p-value of <0.0001) than norms except for bodily pain. The general health domain showed the highest effect size (0.77) and the impact was more pronounced in the SF-36 physical component summary score (0.62) than the mental component summary score (0.46). Older age was correlated with lower scores on the physical component and higher scores on the mental component. Atrial fibrillation and/or systolic heart failure were associated with worse physical health. HRQL was similar in primary vs secondary prevention cases. Inappropriate ICD shock was associated with worse mental health while appropriate therapy trended toward better mental health.

Conclusion

HCM patients with ICDs suffer from poor HRQL regardless of age, sex, or primary vs secondary prevention indication. Atrial fibrillation and systolic heart failure are determinants of poor physical health. Inappropriate shocks, but not appropriate therapies, are associated with poorer mental health.
Literature
1.
Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–79.CrossRefPubMed
2.
Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation. 2000;102:858–64.CrossRefPubMed
3.
Schinkel A, Vriesendorp PA, Sijbrands E, Jordaens L, ten Cate F, Michels M. Outcome and Complications After Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy Systematic Review and Meta-Analysis. Circ Heart Fail. 2012;5:552–9.CrossRefPubMed
4.
Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42:1687–713.CrossRefPubMed
5.
Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2761–96. 2013;166:496-502.CrossRefPubMed
6.
McHorney CA, Ware Jr JE, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40–66.CrossRefPubMed
7.
Sullivan M, Karlsson J, Ware Jr JE. The Swedish SF-36 Health Survey I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med. 1995;41:1349–58.CrossRefPubMed
8.
Steinberg JS, Joshi S, Schron EB, Powell J, Hallstrom A. McBurnie M; AVID Investigators Psychosocial status predicts mortality in patients with life-threatening ventricular arrhythmias. Heart Rhythm. 2008;5:361–5.CrossRefPubMed
9.
Rosman L, Whited A, Lampert R, Mosesso VN, Lawless C, Sears SF. Cardiac anxiety after sudden cardiac arrest: Severity, predictors and clinical implications. Int J Cardiol. 2015;181:73–6.CrossRefPubMed
10.
Redhead AP, Turkington D, Rao S, Tynan MM, Bourke JP. Psychopathology in postinfarction patients implanted with cardioverter-defibrillators for secondary prevention. A cross-sectional, case-controlled study. J Psychosom Res. 2010;69:555–63.CrossRefPubMed
11.
Cox S, O’Donoghue AC, McKenna WJ, Steptoe A. Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy. Heart. 1997;78:182–7.CrossRefPubMedPubMedCentral
12.
Magnusson P, Gadler F, Liv P, Mörner S. Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery. J Cardiovasc Electrophysiol. 2015;26:1088–94.CrossRefPubMed
13.
Cohen J. Statistical Power Analysis for the Behavioral Sciences (2nd ed.) Hillsdale, N.J.:Lawrence Erlbaum Associates (1988).
14.
Hamang A, Eide GE, Nordin K, Rokne B, Bjorvatn C, Øyen N. Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population. BMC Med Genet. 2010;11:27.CrossRefPubMedPubMedCentral
15.
Pedrosa RP, Lima SG, Drager LF, et al. Sleep quality and quality of life in patients with hypertrophic cardiomyopathy. Cardiology. 2010;117:200–6.CrossRefPubMed
16.
Serber ER, Sears SF, Nielsen CD, Spencer 3rd WH, Smith KM. Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation. Am J Cardiol. 2007;100:1592–7.CrossRefPubMed
17.
Gadler F, Linde C, Daubert C, et al. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up. PIC study group. Pacing In Cardiomyopathy. Eur Heart J. 1999;20:1044–50.CrossRefPubMed
18.
Nishimura RA, Trusty JM, Hayes DL, Ilstrup DM, Larsson DR, Hayes SN, et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol. 1997;29:435–41.CrossRefPubMed
19.
Linde C, Gadler F, Kappenberger L, Rydén L. Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy. Am J Cardiol. 1999;83:903–7.CrossRefPubMed
20.
Godemann F, Butter C, Lampe F, Linden M, Werner S, Behrens S. Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD). Qual Life Res. 2004;13:411–6.CrossRefPubMed
21.
Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000;36:1303–9.CrossRefPubMed
22.
Peters-Klimm F, Kunz CU, Laux G, Szecsenyi J, Müller-Tasch T. Patient- and provider-related determinants of generic and specific health-related quality of life of patients with chronic systolic heart failure in primary care: a cross-sectional study. Health Qual Life Outcomes. 2010;8:98.CrossRefPubMedPubMedCentral
23.
Spindler H, Johansen JB, Andersen K, Mortensen P, Pedersen SS. Gender differences in anxiety and concerns about the cardioverter defibrillator. Pacing Clin Electrophysiol. 2009;32:614–21.CrossRefPubMed
24.
Versteeg H, van den Broek KC, Theuns DA, Mommersteeg PM, Alings M, van der Voort PH, et al. Effect of cardiac resynchronization therapy-defibrillator implantation on health status in patients with mild versus moderate symptoms of heart failure. Am J Cardiol. 2011;108:1155–9.CrossRefPubMed
25.
Kikkenborg Berg S, Caspar Thygesen L, Hastrup Svendsen J, Vinggaard Christensen A, Zwisler AD. Anxiety predicts mortality in ICD patients: results from the cross-sectional national CopenHeartICD survey with register follow-up. Pacing Clin Electrophysiol. 2014;37:1641–50.CrossRefPubMed
26.
Berg SK, Pedersen BD, Svendsen JH, Zwisler AD, Kristensen L, Pedersen PU. COPE-ICD: patient experience of participation in an ICD specific rehabilitation programme. Eur J Cardiovasc Nurs. 2012;11(2):207–1527.PubMed
27.
Probst V, Plassard-Kerdoncuf D, Mansourati J, Mabo P, Sacher F, Fruchet C, et al. The psychological impact of implantable cardioverter defibrillator implantation on Brugada syndrome patients. Europace. 2011;13:1034–9.CrossRefPubMed
28.
Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AA, Smets EM. Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A. 2009;149A:602–12.CrossRefPubMed
29.
Hoogwegt MT, Kupper N, Jordaens L, Pedersen SS, Theuns DA. Comorbidity burden is associated with poor psychological well-being and physical health status in patients with an implantable cardioverter-defibrillator. Europace. 2013;15:1468–74.CrossRefPubMed
30.
Johansen JB, Pedersen SS, Spindler H, Andersen K, Nielsen JC, Mortensen PT. Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients. Europace. 2008;10:545–51.CrossRefPubMed
31.
Habibović M, van den Broek KC, Theuns DA, Jordaens L, Alings M, van der Voort PH, et al. Gender disparities in anxiety and quality of life in patients with an implantable cardioverter-defibrillator. Europace. 2011;13:1723-30.CrossRefPubMed
32.
Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;13(367):2275–83.CrossRef
33.
Berg SK, Pedersen PU, Zwisler AD, Winkel P, Gluud C, Pedersen BD, et al. Comprehensive cardiac rehabilitation improves outcome for patients with implantable cardioverter defibrillator. Findings from the COPE-ICD randomised clinical trial. Eur J Cardiovasc Nurs. 2015;14:34–44.CrossRefPubMed
Metadata
Title
Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators
Authors
Peter Magnusson
Stellan Mörner
Fredrik Gadler
Jan Karlsson
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2016
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-016-0467-x

Other articles of this Issue 1/2016

Health and Quality of Life Outcomes 1/2016 Go to the issue

Research

Correlation between health-related quality of life in the physical domain and heart rate variability in asymptomatic adults

Research

Estimating the impact of changes in HbA1c, body weight and insulin injection regimen on health related quality-of-life: a time trade off study

Research

Interpreting change from patient reported outcome (PRO) endpoints: patient global ratings of concept versus patient global ratings of change, a case study among osteoporosis patients

Research

Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis

Research

Explaining parent-child (dis)agreement in generic and short stature-specific health-related quality of life reports: do family and social relationships matter?

Research

The COPD-SIB: a newly developed disease-specific item bank to measure health-related quality of life in patients with chronic obstructive pulmonary disease